In the context of PDT, several approaches for molecular tumor targeting employing nanoconstructs have been used for the photodynamic destruction of tumor cells over-expressing EGFR [65], HER-2 [69,70], and TfR receptors [71]. Here, ERBB2 is linked to neoplasm.